Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-03-10
1990-02-27
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514460, 514824, 549264, A61K 31365, C07D30930
Patent
active
049046918
ABSTRACT:
Disclosed are novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors useful as antihypercholesterolemic agents represented by the formula ##STR1## and the corresponding ring-opened hydroxy acids and esters derived therefrom and pharmaceutically acceptable salts thereof.
Pharmaceutical compositions containing said compounds and method of inhibiting the biosynthesis of cholesterol therewith are also disclosed.
REFERENCES:
patent: 4282155 (1981-08-01), Smith et al.
patent: 4308378 (1981-12-01), Stokker
patent: 4503072 (1985-03-01), Hoffman et al.
patent: 4567289 (1986-01-01), Willard et al.
patent: 4611067 (1986-09-01), Volante et al.
patent: 4622338 (1986-11-01), Boran et al.
patent: 4668699 (1987-05-01), Hoffman et al.
patent: 4681893 (1987-07-01), Roth
patent: 4772626 (1988-09-01), Smith et al.
Neuenschwander Kent W.
Scotese Anthony C.
Balogh Imre (Jim)
Nicholson James A.
Raymond Richard L.
Rorer Pharmaceutical Corporation
Russell Mark W.
LandOfFree
Novel HMG-CoA reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel HMG-CoA reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel HMG-CoA reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-174580